Question 1

Has Shino Bay Aguilera received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,031,108 in general payments to Shino Bay Aguilera across 774 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Shino Bay Aguilera did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Shino Bay Aguilera come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Galderma Laboratories, L.p.	385	$469,334
AbbVie(2 entities)	183	$390,031
Merz North America, Inc.	161	$132,368
Solta Medical, A Division Of Bausch Health US, LLC	15	$29,472
Dermira, Inc.	7	$8,748
Musculoskeletal Transplant Foundation Inc.	7	$504
Revance Therapeutics, Inc.	11	$392
Endo Pharmaceuticals Inc.	2	$195
Biofrontera Inc.	1	$27
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$20
Pierre Fabre Pharmaceuticals, Inc.	1	$17

Shino Bay Aguilera

Payments from drug & device makers

Who reported the general payments

How this compares

Other dermatology in Ft Lauderdale